Avandia

Just moments ago, a Food and Drug Administration (FDA) panel said that clinical data concerning GlaxoSmithKline plc's (NYSE: GSK) diabetes drug, Avandia, is strong enough to raise "significant safety" concerns about the product. Specifically, Dow Jones is reporting that “the current FDA panel voted...

Boeing (NYSE: BA) has presented its proposal to the US Air Force on the next-generation aerial refueling tanker aircraft. The company lagged a day behind its competitor, EADS NV (NYSE: EAD), which submitted its proposal yesterday. The supporters of BA say that the Pentagon should add estimated...